
Effectiveness of azithromycin mass drug administration on trachoma: a systematic review
Author(s) -
Tao Xiong,
Ye Yan,
WenXing Li,
Imti Choonara,
Shamim Qazi,
Hongju Chen,
Jun Tang,
Jing Shi,
Hua Wang,
Zeng Linan,
Bin Xia,
Liang Qiao,
Yi Qu,
Dezhi Mu
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001717
Subject(s) - trachoma , azithromycin , medicine , mass drug administration , trichiasis , randomized controlled trial , chlamydia , systematic review , environmental health , medline , immunology , antibiotics , pathology , population , biology , biochemistry , microbiology and biotechnology
Azithromycin mass drug administration (MDA) is a key part of the strategy for controlling trachoma. This systematic review aimed to comprehensively summarize the present studies of azithromycin MDA on trachoma; provide an overview of the impact of azithromycin MDA on trachoma in different districts; and explore the possible methods to enhance the effectiveness of azithromycin MDA in hyperendemic districts.